| scholarly article | Q13442814 |
| P2093 | author name string | Lee A. Shapiro | |
| Patricia M. Whitaker-Azmitia | |||
| Lynn A. Bialowas-McGoey | |||
| P2860 | cites work | Physiology & Behavior | Q3618986 |
| Folia Neuropathologica | Q15753039 | ||
| Increased protein levels of serotonin transporter in frontal cortex of patients with Down syndrome | Q58365311 | ||
| Analysis of S100A1 Expression During Skeletal Muscle and Neuronal Cell Differentiation | Q62395132 | ||
| S-100 immunoreactivity in rat brain glial cultures is associated with both astrocytes and oligodendrocytes | Q70998342 | ||
| The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases | Q71674774 | ||
| Mechanism of S100 protein-dependent inhibition of glial fibrillary acidic protein (GFAP) polymerization | Q72697203 | ||
| Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition | Q73189536 | ||
| S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702 | Q73505841 | ||
| The comparison of microglia maturation in CNS of normal human fetuses and fetuses with Down's syndrome | Q73517655 | ||
| Increased serum S100B protein in schizophrenia: a study in medication-free patients | Q73711365 | ||
| S100 immunoreactivity is increased in reactive astrocytes of the visual pathways following a mechanical lesion of the rat occipital cortex | Q73825095 | ||
| The serum S100B concentration is age dependent | Q74171237 | ||
| Neurotrophic factor S100 beta in major depression | Q74322174 | ||
| S-100B is increased in melancholic but not in non-melancholic major depression | Q74452780 | ||
| Association of S100B with intermediate filaments and microtubules in glial cells | Q77910503 | ||
| Expression levels of cytoskeletal proteins indicate pathological aging of S100B transgenic mice: an immunohistochemical study of MAP-2, drebrin and GAP-43 | Q80441009 | ||
| Sporadic Creutzfeldt-Jakob disease: the extent of microglia activation is dependent on the biochemical type of PrPSc | Q81332138 | ||
| S100B expression modulates left ventricular remodeling after myocardial infarction in mice | Q81378185 | ||
| Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins | Q24292994 | ||
| Microglia and neuroinflammation: a pathological perspective | Q24799838 | ||
| Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type | Q28139003 | ||
| Intracellular and extracellular roles of S100 proteins | Q28184555 | ||
| The S100 family of EF-hand calcium-binding proteins: functions and pathology | Q28284255 | ||
| Annexin VI binds S100A1 and S100B and blocks the ability of S100A1 and S100B to inhibit desmin and GFAP assemblies into intermediate filaments | Q28293428 | ||
| S100B expression in and effects on microglia | Q28579350 | ||
| S100B in brain damage and neurodegeneration | Q28593720 | ||
| Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro | Q29144178 | ||
| Microglia: active sensor and versatile effector cells in the normal and pathologic brain | Q29547240 | ||
| S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles | Q29620465 | ||
| Expression of S100B during embryonic development of the mouse cerebellum. | Q33278810 | ||
| Reactive microgliosis | Q33604483 | ||
| Rapid prenatal diagnosis of trisomy 21 by real-time quantitative polymerase chain reaction with amplification of small tandem repeats and S100B in chromosome 21 | Q33659051 | ||
| Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes | Q33871786 | ||
| Immune function of microglia | Q34094707 | ||
| Age-related decline of serotonin transporters in living human brain of healthy males | Q34134270 | ||
| Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease | Q34309107 | ||
| The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses | Q34387881 | ||
| Serotonin and brain development: role in human developmental diseases | Q34467013 | ||
| The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease | Q34469528 | ||
| Neurotrophic protein S100 beta stimulates glial cell proliferation | Q34886016 | ||
| S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain | Q35979612 | ||
| Dystrophic serotonergic axons in neurodegenerative diseases. | Q36118481 | ||
| Microglia in health and disease | Q36162118 | ||
| Neurite extension and neuronal survival activities of recombinant S100 beta proteins that differ in the content and position of cysteine residues | Q36222093 | ||
| Structure and function of the brain serotonin system | Q36741599 | ||
| Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice | Q36977935 | ||
| Seizures in HIV-seropositive individuals: NIMHANS experience and review | Q37255317 | ||
| S100beta induction of the proinflammatory cytokine interleukin-6 in neurons | Q37332541 | ||
| Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease | Q37480839 | ||
| Purification and characterization of a neurite extension factor from bovine brain | Q37553120 | ||
| S100 beta induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway | Q48891481 | ||
| Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology | Q48895328 | ||
| Memory and the effect of cold shock in the water maze in S100 beta transgenic mice | Q48952450 | ||
| S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor | Q48969102 | ||
| Vitamin E increases S100B-mediated microglial activation in an S100B-overexpressing mouse model of pathological aging | Q49047427 | ||
| S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha | Q49124580 | ||
| S100B: an old neurotrophic factor with putative new roles in psychiatric illnesses. | Q51962358 | ||
| Serotonin (5-HT) in brains of adult patients with Down syndrome. | Q52171088 | ||
| Estimation of surface area from vertical sections. | Q52639871 | ||
| S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques. | Q53203931 | ||
| Effects of S100A1 and S100B on microtubule stability. An in vitro study using triton-cytoskeletons from astrocyte and myoblast cell lines. | Q55475215 | ||
| The multifaceted profile of activated microglia. | Q37560782 | ||
| Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy | Q37671461 | ||
| Assembly, disassembly, and exchange of glial fibrillary acidic protein | Q39512555 | ||
| The S-100: a protein family in search of a function | Q40418276 | ||
| S-100 in the central nervous system of rat, rabbit and guinea pig during postnatal development | Q40755477 | ||
| Analysis of S100A1 expression during skeletal muscle and neuronal cell differentiation | Q41338705 | ||
| S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells. | Q41863070 | ||
| Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease | Q42452339 | ||
| S100B overexpressing mutant mice exhibit prolonged behavioural and biochemical responses towards repeated intermittent binge treatments with MDMA. | Q42598364 | ||
| The S-100 protein causes an increase of intracellular calcium and death of PC12 cells | Q42810541 | ||
| Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. | Q42877912 | ||
| Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors. | Q43270060 | ||
| Down syndrome patients start early prenatal life with normal cholinergic, monoaminergic and serotoninergic innervation. | Q43842327 | ||
| Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe | Q44370291 | ||
| Transient expression of S-100β immunostaining in developing thalamus and somatosensory cortex of rat | Q44403294 | ||
| Pulmonary and systemic nitric oxide measurements during CCK-5-induced panic attacks | Q44515041 | ||
| Harm avoidance, anxiety, and response to novelty in the adolescent S-100beta transgenic mouse: role of serotonin and relevance to Down syndrome | Q44531001 | ||
| Both aging and chronic fluoxetine increase S100B content in the mouse hippocampus | Q44576804 | ||
| Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression | Q44915202 | ||
| Receptor for advanced glycation endproduct (RAGE)-mediated nuclear factor-kappaB activation in vasculitic neuropathy | Q44916068 | ||
| Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism | Q45188778 | ||
| Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease. | Q45925596 | ||
| Rapid astrocyte and microglial activation following pilocarpine-induced seizures in rats. | Q45941590 | ||
| Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human beta-amyloid | Q46421892 | ||
| Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis | Q46532797 | ||
| Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development | Q46903194 | ||
| Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication | Q47633454 | ||
| Increased clusterin expression in old but not young adult S100B transgenic mice: evidence of neuropathological aging in a model of Down Syndrome | Q47652990 | ||
| Induction of S100b in myocardium: an intrinsic inhibitor of cardiac hypertrophy | Q47791667 | ||
| Over-expression of S100B protein in children with cerebral palsy or delayed development. | Q47926252 | ||
| Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis | Q48225316 | ||
| Aminergic systems in Alzheimer's disease and Parkinson's disease | Q48225859 | ||
| Ameboid microglia as effectors of inflammation in the central nervous system | Q48236906 | ||
| S100B and response to treatment in major depression: a pilot study | Q48240145 | ||
| Microglial and astrocytic cell responses in the rat hippocampus after an intracerebroventricular kainic acid injection | Q48281139 | ||
| Characterization of social behaviors and oxytocinergic neurons in the S-100β overexpressing mouse model of Down Syndrome | Q48313047 | ||
| Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease | Q48313613 | ||
| Cell-specific expression of high levels of human S100 beta in transgenic mouse brain is dependent on gene dosage | Q48413490 | ||
| Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease | Q48417985 | ||
| S-100 beta and insulin-like growth factor-II differentially regulate growth of developing serotonin and dopamine neurons in vitro | Q48427378 | ||
| S100B is increased in mood disorders and may be reduced by antidepressive treatment | Q48479208 | ||
| Cytokine regulation of human microglial cell IL-8 production | Q48532242 | ||
| Arundic Acid ameliorates cerebral amyloidosis and gliosis in Alzheimer transgenic mice | Q48533154 | ||
| Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome | Q48558144 | ||
| A study of the serotonin transporter in the prefrontal cortex in late-life depression and Alzheimer's disease with and without depression | Q48566499 | ||
| Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density. | Q48647860 | ||
| Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits | Q48682281 | ||
| Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease | Q48771318 | ||
| Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology | Q48819891 | ||
| Nerve growth factor inhibits apoptosis induced by S-100 binding in neuronal PC12 cells | Q48825446 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuronitis | Q17157137 |
| Alzheimer's disease | Q11081 | ||
| Down syndrome | Q47715 | ||
| overexpression | Q61643320 | ||
| P304 | page(s) | 797-809 | |
| P577 | publication date | 2010-08-22 | |
| P1433 | published in | Cardiovascular Psychiatry and Neurology | Q26842033 |
| P1476 | title | Effects of S100B on Serotonergic Plasticity and Neuroinflammation in the Hippocampus in Down Syndrome and Alzheimer's Disease: Studies in an S100B Overexpressing Mouse Model | |
| P478 | volume | 2010 |
| Q57808520 | Altered S100 Calcium-Binding Protein B and Matrix Metallopeptidase 9 as Biomarkers of Mesial Temporal Lobe Epilepsy with Hippocampus Sclerosis |
| Q48110984 | Comparative proteome analysis for identification of differentially abundant proteins in SIDS. |
| Q37620620 | Early and sustained altered expression of aging-related genes in young 3xTg-AD mice |
| Q47287966 | Effect of Early-Life Fluoxetine on Anxiety-Like Behaviors in BDNF Val66Met Mice |
| Q48202410 | Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder |
| Q37903240 | Nanoparticles and colloids as contributing factors in neurodegenerative disease |
| Q38857132 | Post-natal Deletion of Neuronal cAMP Responsive-Element Binding (CREB)-1 Promotes Pro-inflammatory Changes in the Mouse Hippocampus. |
Search more.